Room Without a View: Meeting the Increased Demand for Mental Health Treatment During COVID-19
The catastrophic health effects of the coronavirus pandemic are well established, as illustrated by the more than 32 million known cases and over 570,000 COVID-19-related deaths in the United States to date. What has also become more apparent is the immense psychological impact. As a result of the pandemic, much of society is experiencing increased stress in relation to numerous psychosocial factors. This session speaks to the need for increased mental health resources to cope with anxiety and fear about contracting the virus, increased social isolation, separation from family, job loss, economic uncertainty, and grieving the loss of a loved one to the disease.
This activity is supported by an educational grant from AbbVie.
This activity is provided by Global Education Group.”
Learning Objectives
- Discuss the psychological impacts of the COVID-19 pandemic and rise in mental disorders
- Outline strategies to address the increased demand for mental health treatment
- Identify and diagnose patients with depressive and anxiety disorders
- Review initial therapies for patients with depressive and anxiety disorders
- Describe how to implement patient-centered treatment plans by collaborating with patients
Additional Information
Attachment | Size |
---|---|
![]() | 272.93 KB |
Michael R. Clark, MD, MPH, MBA
Professor of Psychiatry and Behavioral Sciences
George Washington School of Medicine and Health Sciences
Baltimore, Maryland
Target Audience
The educational design of this activity addresses the needs of Frontline practitioners, pharmacists, nurse practitioners, psychiatrists, and other healthcare providers involved in the treatment of patients with Mental health disorders and those seeking primary care benefits.
Statement of Need
It is critical for healthcare providers to be able to recognize the signs and symptoms of the mental health disorders that may be affecting their patients as they navigate the challenges of the COVID-19 pandemic. Accurate diagnosis is essential in order to offer effective treatments or to make appropriate referrals to specialists, when necessary. Healthcare professionals can strengthen their diagnostic skills to better evaluate for the presence of depressive and anxiety disorders.
Educational Objectives
After completing this activity, the participant should be better able to:
Discuss the psychological impacts of the COVID-19 pandemic and rise in mental disorders
Outline strategies to address the increased demand for mental health treatment
Identify and diagnose patients with depressive and anxiety disorders
Review initial therapies for patients with depressive and anxiety disorders
Describe how to implement patient-centered treatment plans by collaborating with patients
Faculty
Michael R. Clark, MD, MBA, MPH
Professor of Psychiatry and Behavioral Sciences
George Washington School of Medicine and Health Sciences
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Credit Designation
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-0000-21-416-H01-P)
This is a knowledge-based activity.
Psychology Accreditation Statement
Global Education Group (Global) is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Global maintains responsibility for this program and its content.
This activity has been approved for a maximum of 1.0 CE credits for psychologists. The instructional level of this activity is intermediate
Nurse Practitioner Continuing Education
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0 hour(s) of pharmacology).
Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category 1 credit for completing this program.
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Instructions for Credit
In order to receive credit, participants must complete the course and complete the online credit application, post test, and evaluation form. Participants must receive a passing score of at least 70% on the post test in order to receive credit. Statements of credit are available to print upon completion of the forms.
System Requirements
PC Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) | MAC Mozilla Firefox, Apple Safari, Google Chrome For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above) |
Fee & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter | Reported Financial Relationship |
Michael Clark, MD | Nothing to disclose |
|
|
|
|
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner or Manager | Reported Financial Relationship |
Rhys Williams, MSN, FNP-C, RN | Nothing to disclose |
Kristin Delisi, NP | Nothing to disclose |
Lindsay Borvansky | Nothing to disclose |
Andrea Funk | Nothing to disclose |
Liddy Knight | Nothing to disclose |
Ashley Cann | Nothing to disclose |
Kimberly Rodriguez | Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Available Credit
- 1.00 AANP
- 1.00 ACCME (All Other)
- 1.00 ACCME (MD/DO Only)
- 1.00 ACPE Pharmacy
- 1.00 ANCC